|
|
||||||||
Cardiology Division, Department of Internal Medicine, and Department of Pharmacology, Wayne State University School of Medicine, Detroit, Michigan 48201
| |
ABSTRACT |
|---|
|
|
|---|
Although inactivation of the rapidly activating delayed rectifier current (IKr) limits outward current on depolarization, the role of IKr (and recovery from inactivation) during repolarization is uncertain. To characterize IKr during ventricular repolarization (and compare with the inward rectifier current, IK1), voltage-clamp waveforms simulating the action potential were applied to canine ventricular, atrial, and Purkinje myocytes. In ventricular myocytes, IKr was minimal at plateau potentials but transiently increased during repolarizing ramps. The IKr transient was unaffected by repolarization rate and maximal after 150-ms depolarizations (+25 mV). Action potential clamps revealed the IKr transient terminating the plateau. Although peak IKr transient density was relatively uniform among myocytes, potentials characterizing the peak transients were widely dispersed. In contrast, peak inward rectifier current (IK1) density during repolarization was dispersed, whereas potentials characterizing IK1 defined a narrower (more negative) voltage range. In summary, rapidly activating IKr provides a delayed voltage-dependent (and functionally time-independent) outward transient during ventricular repolarization, consistent with rapid recovery from inactivation. The heterogeneous voltage dependence of IKr provides a novel means for modulating the contribution of this current during repolarization.
arrhythmias; Purkinje fibers; human ether-à-go-go-related gene; atrial myocytes; canine myocardium
| |
INTRODUCTION |
|---|
|
|
|---|
IN MOST MAMMALS (including humans), a rapidly activating component of delayed rectifier current (IKr) is postulated to play a prominent role in defining ventricular repolarization (8, 15, 22, 25). Indeed, most class III antiarrhythmic drugs (as well as some antihistamines and antibiotics with adverse cardiac effects) prolong the action potential duration and ventricular refractoriness, and they may promote torsade de pointes arrhythmias by blocking IKr. Despite the relatively rapid activation kinetics of IKr, its contribution during the action potential plateau is limited by inward rectification. Rectification of IKr has been attributed to rapid inactivation, which reduces outward current at depolarized potentials and contributes to the prolonged plateau phase of the ventricular action potentials (27, 28, 30). Studies of IKr in sinus node cells revealed that rapid recovery from inactivation (along with channel deactivation) occurs during repolarizing square-clamp pulses (26). The role that each process may play in defining IKr during a ventricular action potential is uncertain, because ventricular repolarization is slower than repolarizing square pulses and the gating characteristics of IKr vary between species.
Recent studies have highlighted differences in the densities of various potassium currents across the ventricular wall with implications regarding arrhythmogenesis and antiarrhythmic drug therapy. Heterogeneity of repolarization across the canine ventricular wall has been linked to regional variations in the density of the transient outward current (16) and the slowly activating component of delayed rectifier current (7, 17). Although pharmacological studies suggest that IKr plays a dominant role in defining the ventricular action potential duration, significant differences in ventricular IKr density have not been reported. In Purkinje fibers, direct measurements of IKr have proven difficult (4, 21), despite the fact that block of IKr causes dramatic prolongation of the action potential duration in these tissues (10). Detecting differences in IKr density or characteristics is difficult, because IKr is typically one of the smaller of the potassium repolarizing currents, and its characteristics may not be fully realized using traditional repolarizing square-clamp pulses.
To further characterize and evaluate the involvement of native IKr in ventricular repolarization, voltage-clamp protocols simulating the plateau and repolarization phases of the action potential were applied to isolated canine ventricular myocytes and Purkinje fibers. These results were also contrasted with those from atrial myocytes, allowing for a comparison of IKr characteristics from electrophysiologically distinct preparations and different sets of ionic currents. Results demonstrate that IKr provides a transient "pulse" of outward current later during the ventricular action potential plateau, consistent with its rapid reactivation over the time course of ventricular repolarization. The peak density of the IKr transient is unaffected by repolarization rates encountered physiologically and does not "accumulate" during rapid stimulation if the preceding plateau is sufficiently long to ensure IKr activation. Whereas the peak density of the IKr transient in ventricular myocytes is relatively constant, the voltage characterizing the peak IKr transient varies significantly. This variability provides a novel means for modulating the contribution of IKr during repolarization to affect electrical heterogeneity. In contrast, variability of inward rectifier current (IK1) density is the predominant means by which this current varies between ventricular myocytes. Action potential-clamp techniques (in which the recorded action potential serves as the command waveform) demonstrate the defining role of IKr in the transition to phase 3 (terminal) ventricular repolarization and the activation of IK1 to complete repolarization. Preliminary results have been reported in abstract form (9).
| |
METHODS |
|---|
|
|
|---|
Isolation of Ventricular and Purkinje Myocytes
Cardiac myocytes were obtained after Langendorff perfusion of isolated canine hearts. Briefly, animals were anesthetized with pentobarbital sodium, and hearts were rapidly excised and placed in cold modified Tyrode solution (nominally calcium free) containing (in mM) 110 NaCl, 10 HEPES, 1.2 MgSO4, 24 NaHCO3, 6 KCl, and 11.1 glucose, supplemented with 0.5 mg/ml BSA, adjusted to pH 7.3 with 5 N NaOH, and aerated with 95% O2-5% CO2. The aorta was cannulated, and the heart was flushed with 100 ml of cold Tyrode solution and connected to a heated (37°C) Langendorff perfusion apparatus. After 10 min of additional flushing, the solution was switched to one containing 0.4 mg/ml collagenase (type II, Worthington). After 35 min of recirculation, the heart was removed from the apparatus. To isolate ventricular myocytes, we removed epicardial and endocardial layers, and the remaining left ventricular free wall was minced and agitated for an additional 20 min in an oxygenated shaker bath in enzyme-free Tyrode solution. Dispersed myocytes were subsequently filtered through stainless steel mesh and aliquoted into 15-ml test tubes containing modified Tyrode solution (without BSA). To isolate atrial myocytes, we removed the left atrium after recirculation, and it was minced and manually triturated until remaining chunks were dispersed. Myocytes were kept at room temperature until use (<10 h).To isolate Purkinje cells, we removed larger free-running Purkinje fiber bundles from the heart after collagenase perfusion but before removal of the endocardium. Purkinje fibers were dissected free of endocardial tissues to prevent potential contamination by ventricular myocytes. Fibers were sliced, minced, and manually triturated for 5 min in modified Tyrode solution to free the Purkinje cells from the surrounding collagenase matrix. The distinct morphology of canine Purkinje myocytes (greater length than ventricular myocytes, minimal step-like projections along sides, and "crinkle-cut" surface undulations) confirmed their identity during electrophysiological studies. In a few instances slow, spontaneous, uniform contractions of some cells were observed when cells were placed in a HEPES-buffered solution [containing (in mM) 132 NaCl, 20 HEPES, 1.2 MgSO4, 11.1 glucose, 4 KCl, and 2 CaCl2, adjusted to pH 7.4 with HCl at 37°C], consistent with spontaneous phase 4 depolarization.
Aliquots of isolated myocytes were pipetted onto a heated
(36-37°C) chamber on a Nikon inverted scope as described
previously (7). Myocytes were superfused with the HEPES-buffered
solution. Only rod-like, relaxed myocytes (free from
contraction bands, "bends," and membrane "blebs")
with resting potentials more negative than
75 mV were studied.
Voltage-Clamp Studies
"Traditional" square-clamp pulses and repolarizing ramp
clamps.
For voltage-clamp studies using traditional square-clamp pulses and
repolarizing ramp clamps, whole cell patch-clamp techniques were
applied to myocytes using an Axopatch 200A amplifier (Axon Instruments). Myocytes were accessed with the use of an intracellular solution containing (in mM) 125 K-aspartate, 20 KCl, 10 EGTA, 5 ATP (Mg
salt), 1 MgCl2, and 5 HEPES (free acid), adjusted to pH 7.3 with 5 N KOH. Extracellular solution contained nisoldipine or
nimodipine (1 µM) to block L-type calcium current; contamination by
Na+ current (INa) during potassium
current recordings was prevented by holding the membrane potential at
40 mV before depolarizations to the plateau range of potentials.
Series resistance compensation was typically adjusted to values between
60 and 70%, and recorded potentials were offset negatively by 10 mV
for junction potential as described previously (7).
Action potential clamps. For voltage-clamp studies using action potential waveforms ("action potential clamps," see Ref. 5), perforated-patch techniques were used to minimize alterations of the intercellular milieu (11). Pipette solutions contained (in mM) 130 K-aspartate, 15 KCl, 5 HEPES (free acid), 10 NaCl, and 0.5 CaCl2; 0.18 mg/ml amphotericin B was used as the pore-forming agent. To avoid problems inherent in recording action potential with standard patch-clamp head stages that result from input current in the current-clamp mode (19), an Axoclamp 2B amplifier was used to faithfully record transmembrane potentials (current-clamp mode); voltage clamp was performed as discontinuous single-electrode voltage clamp (or "switch" clamp; typical switching range 4-5 kHz). Action potential waveforms were applied to the same ventricular myocyte from which they were obtained.
Data Interpretation and Analysis
IKr was defined as drug-sensitive current blocked by the specific IKr-blocking agent E-4031, which was prepared from frozen aliquots of 5 mM aqueous stock solution. Except where noted, a 5 µM concentration of E-4031 was used to fully block native IKr (IC50 = 397 nM, Ref. 25). The effects of lower E-4031 concentrations (0.5, 1, and 2.5 µM) were also evaluated in some experiments to assess possible concentration-dependent effects on the configuration of the drug-sensitive current. Because the effects of E-4031 were not readily reversible, drug-sensitive currents were evaluated immediately after bath equilibration (typically <5 min) to minimize the likelihood of nonspecific changes in membrane currents. In select studies, the identification of the E-4031-sensitive current as IKr was confirmed by evaluating the effects of the IKr-blocking agents dofetilide (200 nM, Ref. 10) and sotalol (100 µM, Ref. 2). In additional experiments, extracellular potassium concentration ([K+]o) was reduced to 0 mM to reduce IKr before exposure to E-4031 as a negative control (23).IK1 was defined as current blocked by 20 mM CsCl
(12). To minimize contamination from IKr when
IK1 was being evaluated, we pretreated myocytes
with E-4031 (to block IKr); contamination from
slowly activating delayed rectifier K+ current
(IKs) was minimized by using short (
250 ms),
moderately depolarizing (to
25 mV) square conditioning pulses to
reduce activation of IKs.
Lines were fit by linear regression, and curves were fit by nonlinear least-squares regression analysis (Origin, version 5.0, Microcal Software). t-Tests were used for unpaired samples to evaluate differences between two groups; comparisons between multiple groups were performed using ANOVA with repeated measures followed by appropriate post hoc tests (Systat). Unless otherwise stated, results are presented as means ± SE.
| |
RESULTS |
|---|
|
|
|---|
An IKr Transient Is Present in Ventricular Myocytes
To assess the involvement of IKr during ventricular repolarization, we employed truncated ramp-clamp protocols to simulate the plateau and repolarization phases of the action potential. Figure 1A shows the typical voltage-clamp protocol used. From a holding potential of
85 mV, a 50-ms
depolarizing pulse to
35 mV was applied to inactivate
INa. This step was immediately followed by a 250-ms
pulse to +25 mV (grossly simulating the action potential plateau),
followed by a repolarizing ramp (slope
1.2 V/s) simulating repolarization. Figure 1B shows typical membrane currents
recorded from a ventricular myocyte in the absence (control) and
presence of the specific IKr-blocking agent
E-4031. E-4031 elicited a slight reduction of net outward
current at +25 mV and much greater reduction of outward current early
during the repolarizing ramp. Figure 1C shows the
E-4031-sensitive "difference current" obtained by digital
subtraction of membrane current in the absence and presence of E-4031.
A small drug-sensitive current is rapidly attained during the step
pulse to +25 mV, which transiently increases fourfold during
repolarization, attaining a maximum value at a potential near
48
mV before declining at full repolarization. On the basis of the
specificity of E-4031, we defined the drug-sensitive current transient
as IKr. The transient increase in
IKr during repolarization occurs despite a
continually decreasing electromotive force for potassium ions during
the repolarizing ramp.
|
Three additional series of experiments confirmed the identity of the outward transient as IKr. In one set of experiments, the effects of the IKr-blocking agent dofetilide (200 nM) on outward currents during repolarization were evaluated. In each of four experiments, a dofetilide-sensitive transient was observed analogous to that observed with E-4031. A similar drug-sensitive transient was also apparent when IKr was blocked with 100 µM sotalol. In a second set of experiments, the effects of E-4031 were evaluated in the presence of 0 mM [K+]o to eliminate IKr (23). Under these conditions, the E-4031-sensitive transient current was absent during repolarizing ramp clamps (n = 2 myocytes). Together, these results identified the drug-sensitive outward current transient during repolarization as IKr and not an artifact unique to E-4031. To examine the unlikely possibility that the IKr transient was caused by incremental block (and recovery) of IKr during repolarization, we compared the configuration of the transient during equilibration with lower (500 nM) or higher (5 µM) concentrations of E-4031 in the same myocytes. If the drug-sensitive transient had been caused by time-dependent block, the peak of the current transient would have been expected to shift toward more positive potentials as the drug concentration approached maximum blocking concentrations. In each of four experiments, the amplitude of the drug-sensitive transient increased with greater drug concentration, whereas the shape and voltage characterizing the peak of the transient remained unaltered (data not shown). The lack of effect of drug concentration on the IKr configuration suggests that incremental block of IKr during repolarization is not responsible for the IKr transient.
To determine the time course for activation of the
IKr transient, we clamped ventricular myocytes to
+25 mV for increasing durations before a constant repolarizing ramp.
Clamp protocols were repeated in the absence and presence of E-4031,
and IKr was measured as peak drug-sensitive current
during repolarization for identical clamp sequences. Figure
2A shows the clamp protocol, consisting of a depolarizing step to
35 mV (to inactivate
INa) and a second step to +25 mV ranging from 5 to
155 ms in duration (25-ms increments), followed by a repolarizing ramp
(
1.21 V/s). Figure 2B shows E-4031-sensitive currents
recorded from a typical myocyte (with currents offset by
75 pA
for clarity). It is evident that the amplitude of the
IKr transient increases with longer depolarizing
step pulses. Figure 2C shows averaged results obtained from
seven myocytes, with peak transients normalized as current density.
After a 5-ms step pulse, a small IKr transient is
present that increases after progressively longer depolarizing pulses. The growth of the peak transients was fit to an exponential function with a time constant of 43 ms, attaining half-maximal values within 30 ms. This time constant may slightly overestimate the extent of
IKr activation during the step pulse, because
activation likely continues during early portions of the repolarizing
ramp. Despite the increasing current that follows longer
depolarizations, the voltage of the peak IKr
transients was unaffected (data not shown).
|
In guinea pig myocytes, trains of conditioning depolarizing pulses do
not enhance the amplitude of IKr assessed during
depolarizing ramps (13). To determine whether the
IKr transient is augmented by rapid electrical
activity in canine ventricle, E-4031-sensitive currents were assessed
during repolarizing ramps preceded by conditioning pulse trains;
drug-sensitive currents were obtained using identical pulse protocols.
Preliminary experiments showed that conditioning pulse trains had
minimal effects on the IKr transient when
repolarizing ramps were immediately preceded by a 100-ms step pulse.
These results reflect the nearly complete activation of
IKr during a 100-ms pulse (see Fig. 2). Thus, to
examine possible modulation of the IKr transient
with rapid electrical activity, the duration of the activating pulse
step was set to 12.5 ms. Figure 3A,
top, illustrates the test waveform, whereas Fig. 3B,
inset, illustrates the conditioning pulse protocol,
consisting of trains of 0, 2, or 10 pulses applied before the start of
the transient protocol. Trains consisted of 100-ms conditioning square
pulses to +15 mV with 20-ms interpulse intervals; 13 ms elapsed between
termination of the last conditioning pulse and the start of the
IKr transient test waveform. To maximize
sensitivity when recording these small transients, we repeated
conditioning pulse train/test pulse sequences three times (in the
absence and presence of E-4031) and averaged the results before digital
subtraction was performed. Figure 3A compares typical
E-4031-sensitive currents preceded by either no prepulses or a train of
10 conditioning prepulses. The IKr transient during
repolarization is greater after the conditioning pulse train. Figure
3B summarizes results from 11 myocytes. The peak
IKr transient is enhanced after a 2-pulse
conditioning train and further enhanced after a 10-pulse train. These
results show that the amplitude of the IKr
transient is enhanced by repetitive electrical activity when the test
waveform is sufficiently brief to prevent full activation of
IKr. In each of three additional experiments, no
IKr transient was observed with or without
conditioning pulse trains when myocytes were superfused with 0 mM
[K+]o.
|
To determine whether repolarization rate affected the
IKr transient, we compared E-4031-sensitive
currents during repolarizing ramps of different slopes.
IKr transients were characterized on the basis of
their peak amplitude and the potential at which the peak amplitude
occurred. Experiments employed repolarizing ramps with slopes of
1.21,
0.607, and
0.406 V/s (encompassing rates encountered during ventricular repolarization). Figure
4A shows typical E-4031-sensitive
currents obtained from a ventricular myocyte, with each ramp overlaying
its respective IKr transient. Figure 4B
shows the peak density of IKr transients obtained
from 12 myocytes, along with their average value. Some variability in
the density of the peak transient was apparent, with values ranging
from 0.25 to 0.6 pA/pF (0.44 ± 0.10 pA/pF, mean ± SD). Altering the
rate of repolarization did not affect the amplitude of the peak
transient.
|
Figure 4C compares the potentials at which the peak transients
occurred during repolarizing ramps. The average potential for the peak
transients was slightly more negative for the faster versus slower ramp
speeds (
53.9 vs.
50.1 mV); this difference did not
achieve statistical significance. Significant heterogeneity was
apparent in the voltages characterizing the peak transients, with
values ranging from
33 to
64.7 mV. Heterogeneity was
observed when myocytes from individual hearts as well as myocytes from different hearts were compared, demonstrating that variability in the
cell isolation procedure is not responsible for the voltage heterogeneity.
Figure 4 demonstrates a wide voltage range characterizing the peak
IKr transients. To determine the origin of this
variability, we initially compared the voltage describing the peak
IKr transients with those describing the remaining
outward current peak after IKr blockade, which
occurs at more negative potentials (see Fig. 1). As a working
hypothesis, we attributed the residual outward peak to the inward
rectifier current (IK1), which is activated at more
negative potentials and is responsible for terminal ventricular repolarization and the ventricular resting membrane potential. We
reasoned that the potentials describing both the
IKr and IK1 peaks would be
shifted in the same direction along the voltage axis if the variability
reflected nonspecific changes in individual myocytes. Experimental
results were not consistent with this hypothesis. For the 12 myocytes
studied in Fig. 4, the potential describing the peak
IKr transient ranged from
33 to
64.7
mV (
52.0 ± 7.17 mV, mean ± SD). In contrast, the peak
outward current remaining in the presence of E-4031 spanned a narrower
range over more negative potentials (from
67.1 to
74.7
mV;
70.8 ± 2.3 mV, mean ± SD). These results suggest that
the voltage heterogeneity characterizing IKr
transients is not shared with IK1.
To directly compare dispersion of the voltages describing the peak
amplitudes of IKr and IK1, an
additional series of experiments was conducted comparing the
IKr transient with IK1 in the
same ventricular myocytes. The experimental protocol sequentially
recorded currents during repolarizing ramps 1) under drug-free
(control) conditions, 2) during superfusion with E-4031, and
3) during superfusion with E-4031 and 20 mM CsCl;
drug-sensitive currents (obtained by digital subtraction) were used to
assess IKr (E-4031-sensitive current) and
IK1 (Cs-sensitive current). Currents for each of three ramp slopes (
1.21,
0.607, or
0.406 V/s) for
each myocyte were averaged and compared. Figure
5A shows E-4031-sensitive current (representing IKr) and larger, Cs-sensitive current
(representing IK1) recorded from a myocyte during a
repolarizing ramp. Figure 5B displays current densities and
corresponding potentials characterizing the peak transients for
IKr transient and IK1 from 15 myocytes; individual as well as average values are represented. Results show that the average density of IKr is
approximately fourfold less than that of IK1 and
occurs 24 mV more positively than IK1. The
variability of the IKr density is much less than
that of IK1 (0.38 ± 0.05 vs. 1.46 ± 0.31 pA/pF,
respectively, means ± SD). The greater variability is also reflected
in the coefficient of variation for IKr versus
IK1 (0.132 vs. 0.214, respectively), which
considers relative variation normalized to mean values. Surprisingly,
the voltage range characterizing the peak outward transients is much
wider for IKr than IK1
(
51.7 ± 8.05 vs.
77.0 ± 1.44 mV, respectively, means ± SD). Thus, heterogeneity in the characteristics of
IKr and IK1 can be ascribed to
two different factors, variability in the voltage (but not density) of
peak IKr transients and variability in the current
density (but not voltage range) characterizing IK1.
|
An IKr Transient Is Present in Atrial Myocytes With Characteristics Similar to Those of Ventricular Cells
Results from ventricular cells were contrasted with those from atrial myocytes, allowing for a comparison of IKr characteristics from preparations with electrophysiologically distinct phenotypes and different sets of ionic current. Figure 6A shows currents recorded from an atrial myocyte in the absence and presence of E-4031. The drug-sensitive current is more clearly apparent when two traces are compared because of the paucity of IK1 (and minimal outward current during repolarization) in atrial myocytes (compare Figs. 1 and 6). The lower section displays E-4031-sensitive current, which is similar to that shown for ventricular myocytes. Figure 6, B and C, compares the peak IKr density with the potential of maximal IKr observed with 10 atrial myocytes using 3 different ramp slopes. As shown for ventricular myocytes, the rate of repolarization did not affect either the peak density or peak potential characterizing the IKr transient. Whereas a greater range of densities is apparent when atrial versus ventricular myocytes are compared (compare Figs. 6B and 4B, respectively), the range of peak voltages for both myocyte types was similar (compare Figs. 6C and 4C).
|
IKr Transient Density Is Greater at More Positive Potentials
Because IKr is a potassium current, the peak amplitude of the IKr transient should be greater at potentials farther from the potassium equilibrium potential because of the greater driving force for potassium ions. To determine the relationship between the IKr transient amplitude and the voltage characterizing its peak, these two variables were compared for atrial and ventricular myocytes. Results are shown in Fig. 7; values represent means ± SD derived using the ramp slope protocols from Figs. 4 and 6. For atrial (Fig. 7A) and ventricular (Fig. 7B) myocytes, transients occurring at more positive potentials typically have a greater IKr density. Regression analysis predicts a 0.46 pA/pF increase in peak transient density per each 15-mV positive change in peak potential for atrial myocytes and a 0.24 pA/pF increase for ventricular myocytes. Atrial myocytes displayed a greater range of densities compared with ventricular myocytes (0.927 vs. 0.318 pA/pF, respectively) and greater mean current density (0.62 ± 0.08 vs. 0.44 ± 0.03 pA/pF, P = 0.04, unpaired t-test), with 50% of atrial myocytes showing a greater density than the greatest ventricular value. Despite the overall greater IKr density in atrial myocytes, the range of peak voltages of both myocytes was similar.
|
Direct Demonstration of IKr in Ventricular Repolarization: Action Potential Clamps
The action potential-clamp technique was used to demonstrate the role of the IKr transient during ventricular repolarization. With the use of this technique, action potentials recorded from individual myocytes under drug-free conditions (2-s stimulation rate) were used as the command waveforms in the presence of IKr blockade with E-4031; the difference in membrane current in the absence versus presence of E-4031 was calculated to demonstrate the contribution of IKr during ventricular repolarization. For this series of experiments, perforated-patch techniques were used to minimize alterations in the intracellular milieu, and a discontinuous "single-electrode switch-clamp" technique was used to faithfully record membrane potential, thereby preventing problems associated with action potential recordings obtained with patch-clamp head stages in the current-clamp mode (19). Results are shown in Fig. 8A, which shows 10 consecutive action potentials recorded in the absence (control) and presence of E-4031. E-4031 prolonged the average action potential by reducing the slope of the plateau phase without altering the configuration of the transition to terminal (phase 3) repolarization. Figure 8B shows the average E-4031-sensitive current (IKr) recorded using the action potentials as the command-clamp waveform. The E-4031-sensitive current appears as a linearly increasing outward current superimposed over the drug-free action potential-clamp waveform. IKr peaks at
46 mV, during the
transition from phase 2 to phase 3 repolarization. Block of this small
current (~50-pA peak amplitude) is responsible for the prolongation
of the action potential shown in Fig. 8A. Similar results with
E-4031 were observed in five Purkinje myocytes; a similar configuration
was also observed after IKr block with 1 × 10
4 M sotalol (n = 2 myocytes;
data not shown).
|
IKr Transient Is Present in Purkinje Myocytes
IKr transient was also observed in isolated Purkinje myocytes. Figure 9A shows the voltage-clamp protocol (top) and corresponding membrane currents recorded from a Purkinje myocyte in the absence and presence of E-4031 (middle). Figure 9A, bottom, displays (on an expanded vertical axis) E-4031-sensitive current as a resurgent transient on repolarization. This configuration is consistent with that identified as IKr in ventricular myocytes. This myocyte also displayed reduced outward current on repolarization (consistent with a reduced IK1 density in Purkinje vs. ventricular myocytes, see Ref. 21). Figure 9, B and C, summarizes the effect of repolarization rate on the IKr transient observed with five Purkinje myocytes. As described earlier for ventricular myocytes, the repolarization rate did not affect the amplitude (Fig. 9B) or potential (Fig. 9C) of the peak IKr transient. The average maximal density of the IKr transient from Purkinje myocytes (from all 3 ramp slopes) was 0.494 ± 0.121 pA/pF (mean ± SD), which was not statistically different from that obtained in ventricular myocytes (P = 0.278, power = 0.28). Also, the average potential for the peak IKr transient in Purkinje myocytes (
57.5 ± 17.4 mV, mean ± SD) was not statistically different from that in
ventricular myocytes (P =0.296, power = 0.69). These results
confirm that the IKr transient is present in canine
Purkinje myocytes and is comparable to that of ventricular myocytes. A
more complete characterization of IKr in Purkinje myocytes was not attempted because of the limited number of isolated Purkinje myocytes that retained a relaxed morphology and stable holding
current during recordings.
|
| |
DISCUSSION |
|---|
|
|
|---|
IKr Provides a Transient, Late-Repolarizing Current
This study is the first to characterize an IKr transient in canine myocardium and directly demonstrate its role in ventricular repolarization. An outward current transient during repolarizing ramps was identified as IKr on the basis of the following evidence. 1) Similar transients are elicited during superfusion with three different IKr-blocking agents (E-4031, dofetilide, and sotalol). 2) The E-4031-sensitive outward transient is absent after prior reduction of IKr by superfusion with 0 mM [K+]o. The late outward transient is not an artifact resulting from intracellular dialysis because similar waveforms are observed when perforated-patch techniques are used with action potential clamps. Activation within the plateau range of potentials is sufficient to ensure that most of IKr is available during a 100-ms plateau (Fig. 2). Action potential clamps demonstrate that IKr provides a transient late outward current during the terminal portion of the action potential plateau, promoting the transition to phase 3 repolarization of the canine ventricular action potential. Thus, despite its name, the rapidly activating IKr current contributes substantial significant outward current later during the ventricular action potential as a resurgent outward current that precedes activation of IK1.Shibasaki (26) first suggested that voltage-dependent inactivation was responsible for inward rectification of IKr in rabbit sinoatrial nodal cells superfused in high [K+]o. Subsequent studies described IKr in guinea pig ventricular myocytes as a rapidly activating outward current that contributes minimal current at plateau potentials because of its inward rectification properties (2). Studies suggest that the human ether-à-go-go-related gene (HERG) encodes a potassium ion-selective channel that displays some electrophysiological and pharmacological characteristics similar to those of IKr (24, 29, 32). Studies of HERG expressed in HEK-293 cells or Xenopus oocytes support the role of voltage-gated fast inactivation in the rectification of IKr (27, 28). In these expression systems, rectification results from inactivation that proceeds at a rate faster than activation, limiting outward current on depolarization. IKr and HERG typically display a "hooked" configuration on step repolarization that has been attributed to rapid recovery from inactivation (relative to deactivation) immediately following a repolarizing square-clamp pulse.
On the basis of these reports, the configuration of the
IKr transient during repolarization (in this study)
is most easily explained by assuming rapid voltage-dependent recovery
from inactivation along with slower deactivation kinetics. Because the
amplitude and voltage characterizing the peak IKr
transient are unaffected by repolarization rate (Figs. 4, 6, and 9),
recovery from inactivation must be rapid relative to the physiological
repolarization rates tested. The lack of effect of repolarization rate
on the IKr transient is also consistent with slow
channel deactivation relative to repolarization. Prior studies of
canine IKr demonstrated slow tail-current kinetics
after step repolarizations under experimental conditions identical to
those in this study [time constant of inactivation (
) = 2-3 s at
40 mV, Ref. 7]; two time
constants have also been reported (
values in range of 250-500
ms and 2-20 s, Ref. 17). Slow deactivation kinetics have also been
reported for rabbit (0.8 s, Ref. 3) and cat (0.7 s, from Fig.
7A in Ref. 6) ventricular myocytes and can be gleaned from
studies of human ventricular myocytes (
500 ms at
30 mV,
derived from Fig. 3 in Ref. 15); faster deactivation kinetics have been
reported with guinea pigs (<175 ms near
30 mV, Ref. 25). The
rapid recovery from inactivation and slow deactivation kinetics of
canine IKr provide a voltage-dependent (and
functionally time- independent) outward transient during ventricular
repolarization, analogous to that provided by IK1
at more negative potentials during final repolarization.
In contrast to IK1, greater heterogeneity dispersion is apparent in the potentials characterizing the peak IKr transients (Figs. 4-6). The IKr transient density is typically greater if it occurs at more positive potentials (Fig. 7). Thus the voltage of the peak transient modulates the contribution of IKr during an action potential by two means, namely, 1) by affecting the timing of the transient and 2) by affecting the amplitude of the transient during repolarization. A more detailed kinetics analysis of IKr inactivation in ventricular myocytes [using brief (a few ms) step-clamp protocols] is not technically feasible because of their large capacitance (mean value near 180 pF, unpublished observations) affecting temporal clamp fidelity and the presence of larger time-dependent currents present in this preparation. The use of repolarizing ramps enhances the resolution and characterization of native IKr and provides an effective means to assess the effects of antiarrhythmic drugs and electrophysiological changes accompanying heart disease.
An outward IKr transient is observed during
repolarizing ramps (28) and with imposed action potential clamps (32)
using heterologous expression systems expressing HERG. In oocytes,
expressed peak HERG current increases with progressively slower
repolarizing ramps (range
0.1 to 1 V/s) and peaks at more
negative potentials with faster repolarization (28). In contrast,
native canine IKr amplitude is not affected by ramp
slopes (range
1.21 to
0.4 V/s, Fig. 4) and peaks at
similar potentials as the amplitude grows after longer activating
pulses (Fig. 2). It is uncertain whether these disparate results can be
attributed to differences in experimental conditions, species, or
differences in channel gating. A comparison of results obtained using
native IKr and heterologously expressed HERG
requires caution because of the generally slower kinetics of HERG in
heterologous expression systems, which are exaggerated at lower
experimental temperatures (32). Computer simulations of guinea pig
IKr (assuming instantaneous recovery from
inactivation) predict an outward IKr transient
during repolarization (31) but do not predict variability in the
voltages describing the peak transients. This suggests that other
factors are responsible for modulating native IKr
in ventricular myocytes.
The IKr density in canine ventricular myocytes
measured during repolarizing ramps (0.44 pA/pF, Fig. 4) is more than
twofold greater than that measured during step repolarizing pulses to
40 mV under identical experimental conditions (0.2 pA/pF, Ref. 6). The greater current density with repolarizing ramps is present
despite the reduced driving force for potassium ions (peak IKr transients typically occurring between
45 and
65 mV, see Figs. 4 and 7). The lesser current
density obtained using square repolarizing pulses is consistent with
incomplete recovery from inactivation at
40 mV, which is likely
reduced at more negative potentials during repolarizing ramps. Despite
the greater canine IKr density measured with
repolarizing ramps, these values remain ~50% less than those used in
simulations of guinea pig action potentials on the basis of experiments
utilizing square-clamp pulses (1 pA/pF, Ref. 29, based on Ref. 25). The
greater current density with guinea pig myocytes may contribute to the
shorter action potentials and more rapid heart rates of this species. The mean peak transient current density was statistically greater in
atrial versus ventricular myocytes (0.62 vs. 0.44 pA/pF, P = 0.04, Fig. 7). Whether this represents greater functional
IKr current in all atrial myocytes is uncertain,
because the range of IKr densities for atrial
myocytes overlaps that of ventricular myocytes, and the shorter atrial
action potential duration may limit the extent of
IKr activation. It remains to be determined whether
the greater average transient density in atrial myocytes compensates
for the shorter atrial action potential duration.
IKr Also Provides a Transient, Late-Repolarizing Current in Purkinje Fibers
The present study is the first to demonstrate a delayed IKr transient in Purkinje myocytes with characteristics qualitatively similar to those of ventricular myocytes (Fig. 9). Various IKr-blocking agents significantly prolong the action potential duration of Purkinje fibers (4, 10), suggesting that this current plays a prominent role in defining repolarization in this tissue. However, studies have reported minimal IKr tail currents in canine and rabbit Purkinje myocytes (4, 21). We could detect no statistically significant difference in peak IKr density of canine ventricular and Purkinje myocytes (compare Figs. 4 and 9). Although the possibility exists that small differences in IKr density do exist that may be physiologically significant, the reduced levels of IK1 in Purkinje fibers (4) would ensure a more predominant effect of IKr during repolarization, consistent with greater action potential prolongation generally observed with IKr block in Purkinje versus ventricular myocytes.Possible Mechanism of Heterogeneity of IKr Inactivation
Significant dispersion is apparent in the potentials characterizing the peak IKr transients in atrial, ventricular, and Purkinje myocytes. This wide voltage range describing the current-voltage (I-V) relationship of IKr (Figs. 4-7 and 9) is a novel finding not readily apparent using traditional square-clamp pulses. Because similar variability was not observed for IK1 in the same myocytes (Fig. 5), these differences reflect heterogeneity between myocytes (and not, for example, voltage offsets, which would affect measures of both potassium currents). A number of arguments suggest that the heterogeneity characterizing the peak potential reflects real differences in the voltage dependence of IKr (and not, for example, variability resulting from either measurement errors or the influence of contaminating currents). These arguments include the following findings. 1) The amplitude and voltage of the peak transient are easily determined from the transient configuration on an appropriate vertical scale. 2) The voltage of the peak IKr transients during equilibration with either E-4031 or dofetilide remains unaffected despite the growing transient amplitude. 3) The peak potentials of growing IKr transients that follow progressively longer activating pulses (Fig. 2) remain constant despite the increasing transient amplitude. 4) Standard deviations characterizing peak potentials are comparable for larger- as well as smaller-amplitude transients from different myocytes (Fig. 7). In addition, comparable voltage heterogeneity is observed in the peak potentials of IKr transients of atrial and ventricular myocytes (Fig. 7). This heterogeneity remains despite the greater transient densities present in many atrial myocytes and the different ionic current profiles of these cell types. Because IK1 is minimal in atrial (compared with ventricular) myocytes, the voltage heterogeneity of IKr transients cannot be attributed to the influence of the larger IK1 current in ventricle (which is also maximal at more negative potentials). Finally, because IKr was assessed as drug-sensitive current in these studies, arguments attributing voltage heterogeneity to contaminating currents require that these currents must also be affected by IKr-blocking agents and that the amplitude and voltage dependence of these additional drug-sensitive currents must be such that they "fuse" with IKr to generate a smoothly configured transient; at present, there is no evidence for this effect. Together, these arguments support the (simpler) conclusion that heterogeneity in the voltage dependence of the peak transients reflects a characteristic of native IKr in canine cardiac myocytes.The voltage range characterizing the IKr transients is most easily attributed to differences in the voltage dependence of IKr. A recent study has linked a mutation of HERG associated with long-QT syndrome to a shift in the voltage dependence of steady-state inactivation toward more negative potentials (20). In addition to enhancing rectification and reducing channel availability at positive potentials, this mutation would be expected to shift the peak potential of the IKr transient to more negative potentials, further delaying repolarization. Studies have reported at least two isoforms of ERG in mouse ventricle (14, 18). The expression of these individual isoforms in Xenopus oocytes results in currents with kinetics either slower or faster than those of native IKr, whereas the expression of both isoforms results in intermediate kinetics (comparable to IKr) consistent with the coassembly of heteromultimers. The voltage dependence of the I-V relationship of one of the proposed homomultimers (the relatively rare Merg1a') was shifted by +10 mV compared with either of two other homomultimers or the heteromultimer Merg1a/1b. Although results with the mouse homomultimer likely would not account for the shifts in peak transient potentials observed in the present study, they do raise the possibility that some HERG isoforms may display altered voltage dependence. Whether such isoforms exist in canine myocardium is unknown. A recent study of HERG expressed in Xenopus oocytes showed that a small integral membrane protein [termed minK-related peptide 1 (MiRP1)] assembles with HERG and shifts the voltage dependence of activation in a positive direction without appreciably affecting rapid recovery from inactivation (1). Channels associated with MiRP1 also display reduced single-channel current and increased deactivation rate. The effects of MiRP1 on IKr during repolarizing ramp clamps were not studied and are difficult to predict when oocyte studies (conducted at room temperature) are extrapolated to native channels and physiological temperatures. Thus, it is possible that HERG isoforms, accessory subunits, and/or metabolic factors may contribute toward the heterogeneous voltage dependence of IKr transients; further studies combining cellular and molecular approaches with electrophysiological recordings are necessary to test these hypotheses in native tissues. Because ventricular myocytes in this study were derived from the entire left ventricular midwall, it is unknown whether the variability of IKr is related to anatomic origin within the wall or how it may contribute to the electrophysiological distinctions between isolated epicardial, midmyocardial, and endocardial myocytes.
Functional Consequences of Heterogeneity of the IKr Transient
Differences in the voltage dependence of IKr (rather than differences in current density) represent the predominant means by which variations in IKr contribute to ventricular heterogeneity. In contrast, differences in IK1 density are largely responsible for heterogeneity of this current. The extent to which variations in the voltage dependence of IKr are manifest in cardiac hypertrophy, electrical remodeling of the ventricle, and heart failure require further studies using ramp-clamp protocols. The variability of current density and voltage dependence of currents active during the plateau (where small current variations significantly affect the voltage trajectory) provide additional possibilities to explain regional and disease-related differences in action potential configurations.In summary, this study demonstrates that, despite its rapid activation, IKr provides a delayed outward current transient during repolarization of ventricular myocardium and Purkinje fibers. This resurgent current plays an increasingly prominent role later during the action potential plateau by promoting the initiation of terminal (phase 3) repolarization and activation of IK1. Variability in the voltage dependence of the native IKr transient and variability in the density of IK1 provide two distinct mechanisms for modulating the role of these potassium currents during repolarization and contributing toward ventricular electrical heterogeneity.
| |
ACKNOWLEDGEMENTS |
|---|
Special thanks is offered to Dr. James Marsh for encouragement and support, Dr. R. VanderHeide for assistance with myocyte isolation, and K. Vanderpool for technical assistance. Pfizer Research is thanked for the generous gift of dofetilide and Eisai Pharmaceuticals for E-4031.
| |
FOOTNOTES |
|---|
This work was supported by National Heart, Lung, and Blood Institute Grant R01-HL-49918 and an American Heart Association (Michigan Affiliate) Grant.
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Address for reprint requests and other correspondence: G. A. Gintant, Dept. of Integrative Pharmacology, D46R, Bldg. AP-9, Abbott Laboratories, 100 Abbott Park Rd., Abbott Park, IL 60064-6119 (E-mail: gary.gintant{at}abbott.com).
Received 20 April 1999; accepted in final form 31 August 1999.
| |
REFERENCES |
|---|
|
|
|---|
1.
Abbott, G.,
F. Sesti,
I. Splawski,
M. E. Buck,
M. H. Lehmann,
K. W. Timothy,
M. T. Keating,
and
S. A. N. Goldstein.
MiRP1 forms IKr potassium channels with HERG and is associated with cardiac arrhythmias.
Cell
97:
165-187,
1999[ISI][Medline].
2.
Carmeliet, E.
Electrophysiologic and voltage clamp analysis of the effects of sotalol on isolated cardiac muscle and Purkinje fibers.
J. Pharmacol. Exp. Ther.
232:
817-825,
1985
3.
Clay, J. R.,
A. Ogbaghebriel,
T. Paquette,
B. I. Sasyniuk,
and
A. Shrier.
A quantitative description of the E-4031-sensitive repolarization current in rabbit ventricular myocytes.
Biophys. J.
69:
1830-1837,
1995
4.
Cordeiro, J. M.,
K. W. Spitzer,
and
W. R. Giles.
Repolarizing K+ currents in rabbit heart Purkinje cells.
J. Physiol. (Lond.)
508:
811-823,
1998
5.
Doerr, T.,
R. Denger,
A. Doerr,
and
W. Trautwein.
Ionic current contributing to the action potential in single ventricular myocytes of the guinea pig studied with action potential clamp.
Pflügers Arch.
416:
230-237,
1990[ISI][Medline].
6.
Follmer, C. H.,
and
T. J. Colatsky.
Block of delayed rectifier potassium current, IK, by flecainide and E-4031 in cat ventricular myocytes.
Circulation
82:
284-293,
1990
7.
Gintant, G. A.
Regional differences in IK density in canine left ventricle: role of IK,s in electrical heterogeneity.
Am. J. Physiol. Heart Circ. Physiol.
268:
H604-H613,
1995
8.
Gintant, G. A.
Two components of delayed rectifier current in canine atrium and ventricle. Does IKs play a role in the reverse rate dependence of class III agents?
Circ. Res.
78:
26-37,
1996
9.
Gintant, G. A.
Delayed participation of IKr in ventricular repolarization: direct measures using "action potential" clamps (Abstract).
J. Mol. Cell. Cardiol.
29:
A166,
1997.
10.
Gwilt, M.,
J. E. Arrowsmith,
K. J. Blackburn,
R. A. Burges,
P. E. Cross,
H. W. Drlrymple,
and
A. J. Higgins.
Uk-68,798: a novel, potent and highly selective class III antiarrhythmic agent which blocks potassium channels in cardiac cells.
J. Pharmacol. Exp. Ther.
256:
318-324,
1991
11.
Horn, R.,
and
A. Marty.
Muscarinic activation of ionic currents measured by a new whole-cell recording method.
J. Gen. Physiol.
92:
145-159,
1988
12.
Isenberg, G.
Cardiac Purkinje fibers: cesium as a tool to block inward rectifying potassium currents.
Pflügers Arch.
365:
99-106,
1976[ISI][Medline].
13.
Jurkiewicz, N. K.,
and
M. C. Sanguinetti.
Rate-dependent prolongation of cardiac action potentials by a methanesulfonanilide class III antiarrhythmic agent. Specific block of rapidly activating delayed rectifier K+ current by dofetilide.
Circ. Res.
72:
75-83,
1993
14.
Lees-Miller, J. P.,
C. Kondo,
L. Wang,
and
H. J. Duff.
Electrophysiological characterization of an alternatively processed ERG K+ channel in mouse and human hearts.
Circ. Res.
81:
719-726,
1997
15.
Li, G.-R.,
J. Feng,
L. Yue,
M. Carrier,
and
S. Nattel.
Evidence for two components of delayed rectifier K+ current in human ventricular myocytes.
Circ. Res.
78:
689-696,
1996
16.
Liu, D. W.,
and
C. Antzelevetch.
Characteristics of the delayed rectifier current (IKr and IKs) in canine ventricular epicardial, midmyocardial, and endocardial myocytes. A weaker IKs contributes to the longer action potential of the M cell.
Circ. Res.
76:
351-365,
1995
17.
Liu, D. W.,
G. A. Gintant,
and
C. Antzelevetch.
Ionic basis for electrophysiological distinctions among epicardial, midmyocardial, and endocardial myocytes from the free wall of the canine left ventricle.
Circ. Res.
72:
671-687,
1993
18.
London, B.,
M. C. Trudeau,
K. P. Newton,
A. K. Beyer,
N. G. Copeland,
D. J. Gilbert,
N. A. Jenkins,
C. A. Satler,
and
G. A. Robertson.
Two isoforms of the mouse ether-à-go-go-related gene coassemble to form channels with properties similar to the rapidly activating component of the cardiac delayed rectifier K+ current.
Circ. Res.
81:
870-878,
1997
19.
Magistretti, J.,
M. Mantegazza,
E. Guatteo,
and
E. Wanke.
Action potentials recorded with patch-clamp amplifiers: are they genuine?
Trends Neurosci.
19:
530-534,
1996[ISI][Medline].
20.
Nakajima, T,
T. Furukawa,
T. Tanaka,
Y. Katayama,
R. Nagai,
Y. Nakamura,
and
M. Hiraoka.
Novel mechanism of HERG current suppression in LQT2. Shift in voltage dependence of HERG inactivation.
Circ. Res.
83:
415-422,
1998
21.
Pinto, J. M. B.,
and
P. A. Boyden.
Reduced inward rectifying and increased E-4031-sensitive K+ current density in arrhythmogenic subendocardial Purkinje myocytes from the infarcted heart.
J. Cardiovasc. Electrophysiol.
9:
299-311,
1998[ISI][Medline].
22.
Salata, J. J.,
N. K. Jurkiewicz,
B. Jow,
K. Folander,
P. J. Guinosso, Jr.,
B. Raynor,
R. Swanson,
and
B. Fermini.
IK of rabbit ventricle is composed of two currents: evidence of IKs.
Am. J. Physiol. Heart Circ. Physiol.
271:
H2477-H2489,
1996
23.
Sanguinetti, M. C.,
C. Jiang,
M. E. Curran,
and
M. T. Keating.
A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel.
Cell
81:
299-307,
1995[ISI][Medline].
24.
Sanguinetti, M. C.,
and
N. K. Jurkiewicz.
Two components of cardiac delayed rectifier K+ current: differential sensitivity to block by class III antiarrhythmic agents.
J. Gen. Physiol.
96:
195-215,
1990
25.
Sanguinetti, M. C.,
and
N. K. Jurkiewicz.
Role of external Ca2+ and K+ in gating of cardiac delayed rectifier K+ currents.
Pflügers Arch.
420:
180-186,
1992[ISI][Medline].
26.
Shibasaki, T.
Conductance and kinetics of delayed rectifier potassium channels in nodal cells of the rabbit heart.
J. Physiol. (Lond.)
387:
227-250,
1987
27.
Smith, P. L.,
T. Baukrowitz,
and
G. Yellen.
The inward rectification mechanism of the HERG cardiac potassium channel.
Nature
379:
833-836,
1996[Medline].
28.
Spector, P. S.,
M. E. Curran,
A. Zou,
M. T. Keating,
and
M. C. Sanguinetti.
Fast inactivation causes rectification of the IKr chan